Citadel Advisors LLC Has $4.70 Million Holdings in U.S. Physical Therapy, Inc. (USPH)

Citadel Advisors LLC boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 39,621 shares of the company’s stock after acquiring an additional 1,132 shares during the quarter. Citadel Advisors LLC owned about 0.31% of U.S. Physical Therapy worth $4,699,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its holdings in U.S. Physical Therapy by 6.5% in the 2nd quarter. Wells Fargo & Company MN now owns 102,173 shares of the company’s stock worth $9,810,000 after acquiring an additional 6,244 shares during the period. Northern Trust Corp boosted its stake in shares of U.S. Physical Therapy by 10.3% during the 2nd quarter. Northern Trust Corp now owns 217,737 shares of the company’s stock valued at $20,903,000 after buying an additional 20,295 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of U.S. Physical Therapy by 38.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 5,268 shares of the company’s stock valued at $505,000 after buying an additional 1,456 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of U.S. Physical Therapy by 50.3% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 5,316 shares of the company’s stock valued at $510,000 after buying an additional 1,780 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at approximately $257,000. Hedge funds and other institutional investors own 99.58% of the company’s stock.

U.S. Physical Therapy stock opened at $111.63 on Friday. The company has a market cap of $1.39 billion, a PE ratio of 53.67, a price-to-earnings-growth ratio of 3.81 and a beta of 1.21. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.93 and a quick ratio of 1.93. U.S. Physical Therapy, Inc. has a 52 week low of $70.10 and a 52 week high of $129.65.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, November 1st. The company reported $0.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.06. The company had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $112.79 million. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. U.S. Physical Therapy’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, analysts forecast that U.S. Physical Therapy, Inc. will post 2.55 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 7th. Stockholders of record on Friday, November 9th were paid a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend was Thursday, November 8th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 44.23%.

Several equities analysts have recently commented on the company. TheStreet cut U.S. Physical Therapy from a “b” rating to a “c+” rating in a research note on Friday, November 2nd. Cantor Fitzgerald increased their target price on U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Four analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $113.67.

In related news, CFO Lawrance W. Mcafee sold 3,100 shares of the company’s stock in a transaction that occurred on Friday, November 2nd. The stock was sold at an average price of $113.29, for a total transaction of $351,199.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Mark J. Brookner sold 500 shares of the company’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $118.50, for a total value of $59,250.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,100 shares of company stock valued at $927,949. Company insiders own 2.50% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Citadel Advisors LLC Has $4.70 Million Holdings in U.S. Physical Therapy, Inc. (USPH)” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at https://www.americanbankingnews.com/2018/12/08/citadel-advisors-llc-has-4-70-million-holdings-in-u-s-physical-therapy-inc-usph.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: Stock Symbol

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply